{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T09:12:47Z","timestamp":1792401167947,"version":"4.4.0"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T00:00:00Z","timestamp":1766102400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T00:00:00Z","timestamp":1766102400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100019290","name":"Halmstad University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100019290","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2026,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Rheumatic and musculoskeletal diseases pose a significant and increasing global burden, where axial spondyloarthritis (axSpA) shows a prevalence ranging between 0.2% and 1.6% worldwide. Alongside pharmacological treatments, non-pharmacological exercise interventions are a well-established option for axSpA, offering benefits such as improved disease activity, pain, mobility, and overall quality of life. Moderate-intensity training (MIT) is linked to anti-inflammatory effects, while high-intensity interval training (HIIT) shows promising results for cardiovascular health and to reduce systemic inflammation. Current research emphasizes the need to investigate the effects of MIT and HIIT on inflammation, bone remodeling, and tissue repair. Exercise influences inflammatory biomarkers like C-reactive Protein (CRP), Tumor Necrosis Factor-\u03b1 (TNF-\u03b1), Interleukin-6 (IL-6), and calprotectin, though responses vary by intensity, duration, and disease stage. Further studies are crucial to optimize exercise regimens for axSpA patients by comparing moderate- and high-intensity training concerning their effects on selected blood biomarkers. The aim of this review is to summarize results from studies on specific biomarkers after exercise interventions in individuals with axSpA.<\/jats:p>","DOI":"10.1007\/s11033-025-11373-7","type":"journal-article","created":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T05:16:35Z","timestamp":1766121395000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Inflammatory biomarkers in axial spondyloarthritis and the effect of moderate and high-intensity interval training \u2013 a narrative review"],"prefix":"10.1007","volume":"53","author":[{"given":"Emma","family":"Lienesch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-4399-5480","authenticated-orcid":false,"given":"Johannes","family":"Vo\u00df","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4360-7710","authenticated-orcid":false,"given":"\u00c5sa","family":"Andersson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,19]]},"reference":[{"issue":"1","key":"11373_CR1","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1136\/annrheumdis-2021-222020","volume":"82","author":"JM Gwinnutt","year":"2023","unstructured":"Gwinnutt JM, Wieczorek M, Balanescu A, Bischoff-Ferrari HA, Boonen A, Cavalli G, Souza Sde, Thurah Ade, Dorner TE, Moe RH, Putrik P, Rodr\u00edguez-Carrio J, Silva-Fern\u00e1ndez L, Stamm T, Walker-Bone K, Welling J, Zlatkovi\u0107-\u0160venda MI, Guillemin F, Verstappen SMM (2023) 2021 EULAR recommendations regarding lifestyle behaviours and work participation to prevent progression of rheumatic and musculoskeletal diseases. Ann Rheum Dis 82(1):48\u201356. https:\/\/doi.org\/10.1136\/annrheumdis-2021-222020","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"11373_CR2","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1002\/art.24483","volume":"60","author":"M Rudwaleit","year":"2009","unstructured":"Rudwaleit M, Haibel H, Baraliakos X, Listing J, M\u00e4rker-Hermann E, Zeidler H, Braun J, Sieper J (2009) The early disease stage in axial spondylarthritis: results from the german spondyloarthritis inception cohort. Arthritis Rheum 60(3):717\u2013727. https:\/\/doi.org\/10.1002\/art.24483","journal-title":"Arthritis Rheum"},{"key":"11373_CR3","doi-asserted-by":"publisher","unstructured":"Zhong Z, Huang Y, Liu Y, Chen J, Liu M, Huang Q, Zheng S, Guo X, Deng W, Li T (2021) Correlation between C-Reactive Protein to Albumin Ratio and Disease Activity in Patients with Axial Spondyloarthritis. Disease Markers, 2021, 6642486. https:\/\/doi.org\/10.1155\/2021\/6642486","DOI":"10.1155\/2021\/6642486"},{"issue":"10089","key":"11373_CR4","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/S0140-6736(16)31591-4","volume":"390","author":"J Sieper","year":"2017","unstructured":"Sieper J, Poddubnyy D (2017) Axial spondyloarthritis. Lancet 390(10089):73\u201384. https:\/\/doi.org\/10.1016\/S0140-6736(16)31591-4","journal-title":"Lancet"},{"issue":"2","key":"11373_CR5","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1097\/BOR.0000000000000475","volume":"30","author":"R Wang","year":"2018","unstructured":"Wang R, Ward MM (2018) Epidemiology of axial spondyloarthritis: an update. Curr Opin Rheumatol 30(2):137\u2013143. https:\/\/doi.org\/10.1097\/BOR.0000000000000475","journal-title":"Curr Opin Rheumatol"},{"issue":"3","key":"11373_CR6","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1007\/s10067-021-05968-1","volume":"41","author":"JD Reveille","year":"2022","unstructured":"Reveille JD (2022) Biomarkers in axial spondyloarthritis and low back pain: a comprehensive review. Clin Rheumatol 41(3):617\u2013634. https:\/\/doi.org\/10.1007\/s10067-021-05968-1","journal-title":"Clin Rheumatol"},{"issue":"3","key":"11373_CR7","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s11926-022-01096-0","volume":"25","author":"M Bittar","year":"2023","unstructured":"Bittar M, Khan MA, Magrey M (2023) Axial spondyloarthritis and diagnostic challenges: over-diagnosis, misdiagnosis, and under-diagnosis. Curr Rheumatol Rep 25(3):47\u201355. https:\/\/doi.org\/10.1007\/s11926-022-01096-0","journal-title":"Curr Rheumatol Rep"},{"key":"11373_CR8","doi-asserted-by":"publisher","unstructured":"Rudwaleit M, van der Heijde D, Landew\u00e9 R, Listing J, Akkoc N, Brandt J, Braun J, Chou CT, Collantes-Estevez E, Dougados M, Huang F, Gu J, Khan MA, Kirazli Y, Maksymowych WP, Mielants H, S\u00f8rensen IJ, Ozgocmen S, Roussou E, \u2026 Sieper J (2009) 2. The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II):Validation and final selection. Annals of the Rheumatic Diseases 68(6):777\u2013783. https:\/\/doi.org\/10.1136\/ard.2009.108233","DOI":"10.1136\/ard.2009.108233"},{"key":"11373_CR9","doi-asserted-by":"publisher","unstructured":"Maksymowych WP (2019) Biomarkers for Diagnosis of Axial Spondyloarthritis, Disease Activity, Prognosis, and Prediction of Response to Therapy. Frontiers in Immunology\u00a010. https:\/\/www.frontiersin.org\/journals\/immunology\/articles\/https:\/\/doi.org\/10.3389\/fimmu.2019.00305","DOI":"10.3389\/fimmu.2019.00305"},{"issue":"9","key":"11373_CR10","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.1093\/rheumatology\/kez025","volume":"58","author":"J Rademacher","year":"2019","unstructured":"Rademacher J, Tietz LM, Le L, Hartl A, Hermann K-GA, Sieper J, Mansmann U, Rudwaleit M, Poddubnyy D (2019) Added value of biomarkers compared with clinical parameters for the prediction of radiographic spinal progression in axial spondyloarthritis. Rheumatology 58(9):1556\u20131564. https:\/\/doi.org\/10.1093\/rheumatology\/kez025","journal-title":"Rheumatology"},{"key":"11373_CR11","doi-asserted-by":"publisher","unstructured":"Rausch Osthoff A-K, Niedermann K, Braun J, Adams J, Brodin N, Dagfinrud H, Duruoz T, Esbensen BA, G\u00fcnther K-P, Hurkmans E, Juhl CB, Kennedy N, Kiltz U, Knittle K, Nurmohamed M, Pais S, Severijns G, Swinnen TW, Pitsillidou IA, \u2026 Vlieland TPMV (2018) EULAR recommendations for physical activity in people with inflammatory arthritis and osteoarthritis. Annals of the Rheumatic Diseases 77(9):1251\u20131260. https:\/\/doi.org\/10.1136\/annrheumdis-2018-213585","DOI":"10.1136\/annrheumdis-2018-213585"},{"key":"11373_CR12","doi-asserted-by":"publisher","unstructured":"van der Heijde D, Ramiro S, Landew\u00e9 R, Baraliakos X, Van den Bosch F, Sepriano A, Regel A, Ciurea A, Dagfinrud H, Dougados M, van Gaalen F, G\u00e9her P, van der Horst-Bruinsma I, Inman RD, Jongkees M, Kiltz U, Kvien TK, Machado PM, Marzo-Ortega H, \u2026 Braun J (2017) 2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis. Annals of the Rheumatic Diseases 76(6):978\u2013991. https:\/\/doi.org\/10.1136\/annrheumdis-2016-210770","DOI":"10.1136\/annrheumdis-2016-210770"},{"issue":"Suppl 4","key":"11373_CR13","doi-asserted-by":"publisher","first-page":"iv79","DOI":"10.1093\/rheumatology\/keaa435","volume":"59","author":"GE Fragoulis","year":"2020","unstructured":"Fragoulis GE, Siebert S (2020) Treatment strategies in axial spondyloarthritis: what, when and how? Rheumatology (Oxford) 59(Suppl 4):iv79\u2013iv89. https:\/\/doi.org\/10.1093\/rheumatology\/keaa435","journal-title":"Rheumatology (Oxford)"},{"key":"11373_CR14","doi-asserted-by":"publisher","unstructured":"Ramiro S, Nikiphorou E, Sepriano A, Ortolan A, Webers C, Baraliakos X, Landew\u00e9 RBM, Bosch FEV den Boteva B, Bremander A, Carron P, Ciurea A, Gaalen FA, van G\u00e9her P, Gensler L, Hermann J, Hooge M de Husakova M, Kiltz U, \u2026 Heijde D van der (2023). ASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 update. Annals of the Rheumatic Disease, 82(1):19\u201334. https:\/\/doi.org\/10.1136\/ard-2022-223296","DOI":"10.1136\/ard-2022-223296"},{"issue":"1","key":"11373_CR15","doi-asserted-by":"publisher","first-page":"e000397","DOI":"10.1136\/rmdopen-2016-000397","volume":"3","author":"A Regel","year":"2017","unstructured":"Regel A, Sepriano A, Baraliakos X, van der Heijde D, Braun J, Landew\u00e9 R, Van den Bosch F, Falzon L, Ramiro S (2017) Efficacy and safety of non-pharmacological and non-biological pharmacological treatment: a systematic literature review informing the 2016 update of the ASAS\/EULAR recommendations for the management of axial spondyloarthritis. RMD Open 3(1):e000397. https:\/\/doi.org\/10.1136\/rmdopen-2016-000397","journal-title":"RMD Open"},{"issue":"4","key":"11373_CR16","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1007\/s40744-019-00170-x","volume":"6","author":"FM Perrotta","year":"2019","unstructured":"Perrotta FM, Musto A, Lubrano E (2019) New insights in physical therapy and rehabilitation in axial spondyloarthritis: a review. Rheumatol Ther 6(4):479\u2013486. https:\/\/doi.org\/10.1007\/s40744-019-00170-x","journal-title":"Rheumatol Ther"},{"key":"11373_CR17","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.782150","volume":"8","author":"E Toussirot","year":"2021","unstructured":"Toussirot E (2021) The risk of cardiovascular diseases in axial spondyloarthritis. Current insights. Front Med (Lausanne) 8:782150. https:\/\/doi.org\/10.3389\/fmed.2021.782150","journal-title":"Front Med (Lausanne)"},{"issue":"5","key":"11373_CR18","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1136\/bjsports-2018-099943","volume":"54","author":"SH Sveaas","year":"2020","unstructured":"Sveaas SH, Bilberg A, Berg IJ, Provan SA, Rollefstad S, Semb AG, Hagen KB, Johansen MW, Pedersen E, Dagfinrud H (2020) High intensity exercise for 3 months reduces disease activity in axial spondyloarthritis (axSpA): a multicentre randomised trial of 100 patients. Br J Sports Med 54(5):292\u2013297. https:\/\/doi.org\/10.1136\/bjsports-2018-099943","journal-title":"Br J Sports Med"},{"issue":"5","key":"11373_CR19","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1002\/art.30277","volume":"63","author":"CC Mok","year":"2011","unstructured":"Mok CC, Kwok CL, Ho LY, Chan PT, Yip SF (2011) Life expectancy, standardized mortality ratios, and causes of death in six rheumatic diseases in Hong Kong, China. Arthritis Rheum 63(5):1182\u20131189. https:\/\/doi.org\/10.1002\/art.30277","journal-title":"Arthritis Rheum"},{"key":"11373_CR20","doi-asserted-by":"publisher","unstructured":"Navarini L, Currado D, Marino A, Di Donato S, Biaggi A, Caso F, Costa L, Tasso M, Ruscitti P, Pavlych V, Berardicurti O, Ciancio A, Pantano I, Camarda F, Chimenti MS D\u2019Antonio A, Ursini F, Corrado A, Cantatore FP, \u2026 Giacomelli R (2022). Persistence of C-reactive protein increased levels and high disease activity are predictors of cardiovascular disease in patients with axial spondyloarthritis. Scientific Reports 12:7498. https:\/\/doi.org\/10.1038\/s41598-022-11640-8","DOI":"10.1038\/s41598-022-11640-8"},{"key":"11373_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cyto.2015.10.003","volume":"77","author":"GP Dorneles","year":"2016","unstructured":"Dorneles GP, Haddad DO, Fagundes VO, Vargas BK, Kloecker A, Rom\u00e3o PRT, Peres A (2016) High intensity interval exercise decreases IL-8 and enhances the immunomodulatory cytokine interleukin-10 in lean and overweight\u2013obese individuals. Cytokine 77:1\u20139. https:\/\/doi.org\/10.1016\/j.cyto.2015.10.003","journal-title":"Cytokine"},{"issue":"23","key":"11373_CR22","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph182312644","volume":"18","author":"JM Leiva-Valderrama","year":"2021","unstructured":"Leiva-Valderrama JM, Montes-de-Oca-Garcia A, Opazo-Diaz E, Ponce-Gonzalez JG, Molina-Torres G, Vel\u00e1zquez-D\u00edaz D, Gal\u00e1n-Mercant A (2021) Effects of high-intensity interval training on inflammatory biomarkers in patients with type 2 diabetes. A systematic review. Int J Environ Res Public Health 18(23):12644. https:\/\/doi.org\/10.3390\/ijerph182312644","journal-title":"Int J Environ Res Public Health"},{"issue":"217","key":"11373_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.apunsm.2023.100404","volume":"58","author":"B Rohnejad","year":"2023","unstructured":"Rohnejad B, Monazzami A (2023) Effects of high-intensity intermittent training on some inflammatory and muscle damage indices in overweight middle-aged men. Apunts Med Esport 58(217):100404. https:\/\/doi.org\/10.1016\/j.apunsm.2023.100404","journal-title":"Apunts Med Esport"},{"issue":"2","key":"11373_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.berh.2020.101504","volume":"34","author":"GS Metsios","year":"2020","unstructured":"Metsios GS, Moe RH, Kitas GD (2020) Exercise and inflammation. Best Practice & Research Clinical Rheumatology 34(2):101504. https:\/\/doi.org\/10.1016\/j.berh.2020.101504","journal-title":"Best Practice & Research Clinical Rheumatology"},{"key":"11373_CR25","doi-asserted-by":"publisher","unstructured":"MacIntosh BR, Murias JM, Keir DA, Weir JM (2021) What is moderate to vigorous exercise intensity? Front Physiol 12. https:\/\/doi.org\/10.3389\/fphys.2021.682233","DOI":"10.3389\/fphys.2021.682233"},{"issue":"3","key":"11373_CR26","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1177\/1559827607300283","volume":"1","author":"MG Flynn","year":"2007","unstructured":"Flynn MG, McFarlin BK, Markofski MM (2007) The anti-inflammatory actions of exercise training. Am J Lifestyle Med 1(3):220. https:\/\/doi.org\/10.1177\/1559827607300283","journal-title":"Am J Lifestyle Med"},{"issue":"4","key":"11373_CR27","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1152\/japplphysiol.00164.2004","volume":"98","author":"AMW Petersen","year":"2005","unstructured":"Petersen AMW, Pedersen BK (2005) The anti-inflammatory effect of exercise. J Appl Physiol 98(4):1154\u20131162. https:\/\/doi.org\/10.1152\/japplphysiol.00164.2004","journal-title":"J Appl Physiol"},{"key":"11373_CR28","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1515\/hukin-2017-0031","volume":"56","author":"L Cipryan","year":"2017","unstructured":"Cipryan L (2017) IL-6, antioxidant capacity and muscle damage markers following high-intensity interval training protocols. J Hum Kinet 56:139\u2013148. https:\/\/doi.org\/10.1515\/hukin-2017-0031","journal-title":"J Hum Kinet"},{"issue":"10","key":"11373_CR29","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3390\/nu14101996","volume":"14","author":"D Reljic","year":"2022","unstructured":"Reljic D, Dieterich W, Herrmann HJ, Neurath MF, Zopf Y (2022) HIIT the Inflammation: Comparative Effects of Low-Volume Interval Training and Resistance Exercises on Inflammatory Indices in Obese Metabolic Syndrome Patients Undergoing Caloric Restriction. Nutrients 14(10):10. https:\/\/doi.org\/10.3390\/nu14101996","journal-title":"Nutrients"},{"issue":"2","key":"11373_CR30","doi-asserted-by":"publisher","first-page":"191","DOI":"10.5114\/aoms.2013.33181","volume":"9","author":"M Coelho","year":"2013","unstructured":"Coelho M, Oliveira T, Fernandes R (2013) Biochemistry of adipose tissue: an endocrine organ. Archives Med Science: AMS 9(2):191\u2013200. https:\/\/doi.org\/10.5114\/aoms.2013.33181","journal-title":"Archives Med Science: AMS"},{"issue":"11","key":"11373_CR31","doi-asserted-by":"publisher","first-page":"2020","DOI":"10.1111\/sms.13754","volume":"30","author":"M Khalafi","year":"2020","unstructured":"Khalafi M, Symonds ME (2020) The impact of high-intensity interval training on inflammatory markers in metabolic disorders: a meta-analysis. Scand J Med Sci Sports 30(11):2020\u20132036. https:\/\/doi.org\/10.1111\/sms.13754","journal-title":"Scand J Med Sci Sports"},{"issue":"1","key":"11373_CR32","doi-asserted-by":"publisher","first-page":"e001480","DOI":"10.1136\/rmdopen-2020-001480","volume":"7","author":"FM Perrotta","year":"2021","unstructured":"Perrotta FM, Lories R, Lubrano E (2021) To move or not to move: the paradoxical effect of physical exercise in axial spondyloarthritis. RMD Open 7(1):e001480. https:\/\/doi.org\/10.1136\/rmdopen-2020-001480","journal-title":"RMD Open"},{"issue":"4","key":"11373_CR33","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1002\/acr.20364","volume":"63","author":"S Mathieu","year":"2011","unstructured":"Mathieu S, Gossec L, Dougados M, Soubrier M (2011) Cardiovascular profile in ankylosing spondylitis: a systematic review and meta-analysis. Arthritis Care Res 63(4):557\u2013563. https:\/\/doi.org\/10.1002\/acr.20364","journal-title":"Arthritis Care Res"},{"key":"11373_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2174\/1874192401307010001","volume":"7","author":"TA Rehn","year":"2013","unstructured":"Rehn TA, Winett RA, Wisl\u00f8ff U, Rognmo \u00d8 (2013) Increasing physical activity of high intensity to reduce the prevalence of chronic diseases and improve public health. Open Cardiovasc Med J 7:1\u20138. https:\/\/doi.org\/10.2174\/1874192401307010001","journal-title":"Open Cardiovasc Med J"},{"issue":"4","key":"11373_CR35","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.semarthrit.2015.08.003","volume":"45","author":"JR Millner","year":"2016","unstructured":"Millner JR, Barron JS, Beinke KM, Butterworth RH, Chasle BE, Dutton LJ, Lewington MA, Lim EGS, Morley TB, O\u2019Reilly JE, Pickering KA, Winzenberg T, Zochling J (2016) Exercise for ankylosing spondylitis: an evidence-based consensus statement. Semin Arthritis Rheum 45(4):411\u2013427. https:\/\/doi.org\/10.1016\/j.semarthrit.2015.08.003","journal-title":"Semin Arthritis Rheum"},{"key":"11373_CR36","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2020.567881","volume":"11","author":"ML Bay","year":"2020","unstructured":"Bay ML, Pedersen BK (2020) Muscle-organ crosstalk: focus on immunometabolism. Front Physiol 11:567881. https:\/\/doi.org\/10.3389\/fphys.2020.567881","journal-title":"Front Physiol"},{"key":"11373_CR37","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2014.193","author":"FB Benatti","year":"2015","unstructured":"Benatti FB, Pedersen BK (2015) Exercise as an anti-inflammatory therapy for rheumatic diseases\u2014myokine regulation. Nat Rev Rheumatol. https:\/\/doi.org\/10.1038\/nrrheum.2014.193","journal-title":"Nat Rev Rheumatol"},{"key":"11373_CR38","doi-asserted-by":"publisher","unstructured":"Lorenzin M, Ortolan A, Felicetti M, Favero M, Vio S, Zaninotto M, Polito P, Cosma C, Scapin V, Lacognata C, Ramonda R (2019) Serological Biomarkers in Early Axial Spondyloarthritis During 24-Months Follow Up (Italian Arm of Space Study). Frontiers in Medicine\u00a06. https:\/\/www.frontiersin.org\/articles\/https:\/\/doi.org\/10.3389\/fmed.2019.00177","DOI":"10.3389\/fmed.2019.00177"},{"issue":"5","key":"11373_CR39","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1097\/AJP.0000000000000810","volume":"36","author":"YZ Lim","year":"2020","unstructured":"Lim YZ, Wang Y, Cicuttini FM, Hughes HJ, Chou L, Urquhart DM, Ong PX, Hussain SM (2020) Association between inflammatory biomarkers and nonspecific low back pain: a systematic review. Clin J Pain 36(5):379\u2013389. https:\/\/doi.org\/10.1097\/AJP.0000000000000810","journal-title":"Clin J Pain"},{"issue":"Supplement_4","key":"11373_CR40","doi-asserted-by":"publisher","first-page":"iv38","DOI":"10.1093\/rheumatology\/keaa543","volume":"59","author":"T Rusman","year":"2020","unstructured":"Rusman T, van Bentum RE, van der Horst-Bruinsma IE (2020) Sex and gender differences in axial spondyloarthritis: myths and truths. Rheumatology 59(Supplement_4):iv38\u2013iv46. https:\/\/doi.org\/10.1093\/rheumatology\/keaa543","journal-title":"Rheumatology"},{"issue":"11","key":"11373_CR41","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1002\/art.24838","volume":"61","author":"MK de Vries","year":"2009","unstructured":"de Vries MK, van Eijk IC, van der Horst-bruinsma IE, Peters MJL, Nurmohamed MT, Dijkmans BAC, Hazenberg BPC, Wolbink GJ (2009) Erythrocyte sedimentation rate, C-reactive protein level, and serum amyloid A protein for patient selection and monitoring of anti\u2013tumor necrosis factor treatment in ankylosing spondylitis. Arthritis Care & Research 61(11):1484\u20131490. https:\/\/doi.org\/10.1002\/art.24838","journal-title":"Arthritis Care & Research"},{"key":"11373_CR42","doi-asserted-by":"publisher","unstructured":"Pedersen, S. J., S\u00f8rensen, I. J., Garnero, P., Johansen, J. S., Madsen, O. R., Tvede,N., Hansen, M. S., Thamsborg, G., Andersen, L. S., Majgaard, O., Loft, A. G., Erlendsson,J., Asmussen, K., Jurik, A. G., M\u00f8ller, J., Hasselquist, M., Mikkelsen, D., Skj\u00f8dt,T., Lambert, R., \u2026 stergaard, M. (2011). ASDAS, BASDAI and different treatment responses and their relation to biomarkers of inflammation, cartilage and bone turnover in patients with axial spondyloarthritis treated with TNF\u03b1 inhibitors. Annals of the Rheumatic Diseases 70(8):1375\u20131381. https:\/\/doi.org\/10.1136\/ard.2010.138883","DOI":"10.1136\/ard.2010.138883"},{"issue":"6","key":"11373_CR43","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1016\/j.jshs.2023.07.001","volume":"12","author":"A Isanejad","year":"2023","unstructured":"Isanejad A, Nazari S, Gharib B, Motlagh AG (2023) Comparison of the effects of high-intensity interval and moderate-intensity continuous training on inflammatory markers, cardiorespiratory fitness, and quality of life in breast cancer patients. J Sport Health Sci 12(6):674. https:\/\/doi.org\/10.1016\/j.jshs.2023.07.001","journal-title":"J Sport Health Sci"},{"issue":"14","key":"11373_CR44","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1007\/s40265-018-0971-x","volume":"78","author":"SJ Pedersen","year":"2018","unstructured":"Pedersen SJ, Maksymowych WP (2018) Beyond the TNF-\u03b1 inhibitors: new and emerging targeted therapies for patients with axial spondyloarthritis and their relation to pathophysiology. Drugs 78(14):1397\u20131418. https:\/\/doi.org\/10.1007\/s40265-018-0971-x","journal-title":"Drugs"},{"key":"11373_CR45","doi-asserted-by":"publisher","unstructured":"Gonzalez-Lopez L, Fajardo-Robledo NS, Salda\u00f1a-Cruz M, Moreno-Sandoval A, Bonilla-Lara IV, Zavaleta-Mu\u00f1iz D, Nava-Zavala S, Hernandez-Cuervo AH, Rocha-Mu\u00f1oz P, Rodriguez-Jimenez A, Vazquez-Villegas NA, Mu\u00f1oz-Valle ML, Salazar-Paramo JF, Cardona-Mu\u00f1oz EG, Gamez-Nava JI (2017). Association of adipokines, interleukin-6, and tumor necrosis factor-\u03b1 concentrations with clinical characteristics and presence of spinal syndesmophytes in patients with ankylosing spondylitis: A cross-sectional study. The Journal of International Medical Research\u00a045(3):1024\u20131035. https:\/\/doi.org\/10.1177\/0300060517708693","DOI":"10.1177\/0300060517708693"},{"key":"11373_CR46","doi-asserted-by":"publisher","first-page":"565275","DOI":"10.3389\/fimmu.2020.565275","volume":"11","author":"X Wu","year":"2020","unstructured":"Wu X (2020) Innate lymphocytes in inflammatory arthritis. Front Immunol 11:565275. https:\/\/doi.org\/10.3389\/fimmu.2020.565275","journal-title":"Front Immunol"},{"issue":"2","key":"11373_CR47","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1093\/labmed\/lmab029","volume":"53","author":"J Du","year":"2022","unstructured":"Du J, Sun J, Wen Z, Wu Z, Li Q, Xia Y, Yang Q, Yang C (2022) Serum IL-6 and TNF-\u03b1 levels are correlated with disease severity in patients with ankylosing spondylitis. Lab Med 53(2):149\u2013155. https:\/\/doi.org\/10.1093\/labmed\/lmab029","journal-title":"Lab Med"},{"issue":"10","key":"11373_CR48","first-page":"17362","volume":"8","author":"W Liu","year":"2015","unstructured":"Liu W, Wu Y-H, Zhang L, Liu X-Y, Xue B, Wang Y, Liu B, Jiang Q, Kwang H-W, Wu D-J (2015) Elevated serum levels of IL-6 and IL-17 May associate with the development of ankylosing spondylitis. Int J Clin Exp Med 8(10):17362\u201317376. https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC4694228\/","journal-title":"Int J Clin Exp Med"},{"key":"11373_CR49","doi-asserted-by":"publisher","first-page":"641734","DOI":"10.3389\/fmolb.2021.641734","volume":"8","author":"P Villar-Fincheira","year":"2021","unstructured":"Villar-Fincheira P, Sanhueza-Olivares F, Norambuena-Soto I, Cancino-Arenas N, Hernandez-Vargas F, Troncoso R, Gabrielli L, Chiong M (2021) Role of Interleukin-6 in vascular health and disease. Front Mol Biosci 8:641734. https:\/\/doi.org\/10.3389\/fmolb.2021.641734","journal-title":"Front Mol Biosci"},{"issue":"4","key":"11373_CR50","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1152\/physrev.90100.2007","volume":"88","author":"BK Pedersen","year":"2008","unstructured":"Pedersen BK, Febbraio MA (2008) Muscle as an endocrine organ: focus on Muscle-Derived Interleukin-6. Physiol Rev 88(4):1379\u20131406. https:\/\/doi.org\/10.1152\/physrev.90100.2007","journal-title":"Physiol Rev"},{"issue":"4","key":"11373_CR51","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1080\/02640414.2019.1706829","volume":"38","author":"R Martland","year":"2020","unstructured":"Martland R, Mondelli V, Gaughran F, Stubbs B (2020) Can high-intensity interval training improve physical and mental health outcomes? A meta-review of 33 systematic reviews across the lifespan. J Sports Sci 38(4):430\u2013469. https:\/\/doi.org\/10.1080\/02640414.2019.1706829","journal-title":"J Sports Sci"},{"issue":"3","key":"11373_CR52","first-page":"352","volume":"22","author":"\u00d6 Eken","year":"2022","unstructured":"Eken \u00d6, Kafkas ME (2022) Effects of low and high intensity interval training exercises on VO2max and components of neuromuscular and vascular system in male volunteers. J Musculoskel Neuronal Interact 22(3):352\u2013363. https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC9438513\/","journal-title":"J Musculoskel Neuronal Interact"},{"issue":"12","key":"11373_CR53","doi-asserted-by":"publisher","first-page":"2137","DOI":"10.1136\/annrheumdis-2013-203824","volume":"73","author":"D Poddubnyy","year":"2014","unstructured":"Poddubnyy D, Conrad K, Haibel H, Syrbe U, Appel H, Braun J, Rudwaleit M, Sieper J (2014) Elevated serum level of the vascular endothelial growth factor predicts radiographic spinal progression in patients with axial spondyloarthritis. Ann Rheum Dis 73(12):2137\u20132143. https:\/\/doi.org\/10.1136\/annrheumdis-2013-203824","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"11373_CR54","doi-asserted-by":"publisher","DOI":"10.1186\/ar2537","volume":"10","author":"H Appel","year":"2008","unstructured":"Appel H, Janssen L, Listing J, Heydrich R, Rudwaleit M, Sieper J (2008) Serum levels of biomarkers of bone and cartilage destruction and new bone formation in different cohorts of patients with axial spondyloarthritis with and without tumor necrosis factor-alpha blocker treatment. Arthritis Res Ther 10(5):R125. https:\/\/doi.org\/10.1186\/ar2537","journal-title":"Arthritis Res Ther"},{"issue":"11","key":"11373_CR55","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1007\/s10067-010-1528-x","volume":"29","author":"SJ Pedersen","year":"2010","unstructured":"Pedersen SJ, Hetland ML, S\u00f8rensen IJ, \u00d8stergaard M, Nielsen HJ, Johansen JS (2010) Circulating levels of interleukin-6, vascular endothelial growth factor, YKL-40, matrix metalloproteinase-3, and total Aggrecan in spondyloarthritis patients during 3 years of treatment with TNF\u03b1 inhibitors. Clin Rheumatol 29(11):1301\u20131309. https:\/\/doi.org\/10.1007\/s10067-010-1528-x","journal-title":"Clin Rheumatol"},{"issue":"3","key":"11373_CR56","doi-asserted-by":"publisher","first-page":"H326","DOI":"10.1152\/ajpheart.00635.2015","volume":"310","author":"IM Olfert","year":"2016","unstructured":"Olfert IM, Baum O, Hellsten Y, Egginton S (2016) Advances and challenges in skeletal muscle angiogenesis. Am J Physiol-Heart Circ Physiol 310(3):H326\u2013H336. https:\/\/doi.org\/10.1152\/ajpheart.00635.2015","journal-title":"Am J Physiol-Heart Circ Physiol"},{"issue":"6","key":"11373_CR57","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1519\/JSC.0000000000002933","volume":"35","author":"B Kliszczewicz","year":"2021","unstructured":"Kliszczewicz B, Markert CD, Bechke E, Williamson C, Clemons KN, Snarr RL, McKenzie MJ (2021) Acute effect of popular High-Intensity functional training exercise on physiologic markers of growth. J Strength Cond Res 35(6):1677. https:\/\/doi.org\/10.1519\/JSC.0000000000002933","journal-title":"J Strength Cond Res"},{"key":"11373_CR58","doi-asserted-by":"publisher","first-page":"125","DOI":"10.2478\/hukin-2019-0137","volume":"73","author":"G Manferdelli","year":"2020","unstructured":"Manferdelli G, Freitag N, Doma K, Hackney AC, Predel H-G, Bloch W, Schumann M (2020) Acute hormonal responses to High-Intensity interval training in hyperoxia. J Hum Kinet 73:125\u2013134. https:\/\/doi.org\/10.2478\/hukin-2019-0137","journal-title":"J Hum Kinet"},{"issue":"Pt 14","key":"11373_CR59","doi-asserted-by":"publisher","first-page":"3551","DOI":"10.1113\/jphysiol.2008.153551","volume":"586","author":"OH Mortensen","year":"2008","unstructured":"Mortensen OH, Andersen K, Fischer C, Nielsen AR, Nielsen S, \u00c5kerstr\u00f6m T, Aastr\u00f8m M, Borup R, Pedersen BK (2008) Calprotectin is released from human skeletal muscle tissue during exercise. J Physiol 586(Pt 14):3551. https:\/\/doi.org\/10.1113\/jphysiol.2008.153551","journal-title":"J Physiol"},{"issue":"1","key":"11373_CR60","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-016-1180-1","volume":"18","author":"A Levitova","year":"2016","unstructured":"Levitova A, Hulejova H, Spiritovic M, Pavelka K, Senolt L, Husakova M (2016) Clinical improvement and reduction in serum calprotectin levels after an intensive exercise programme for patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis. Arthritis Res Ther 18(1):275. https:\/\/doi.org\/10.1186\/s13075-016-1180-1","journal-title":"Arthritis Res Ther"},{"key":"11373_CR61","doi-asserted-by":"publisher","unstructured":"Jarlborg M, Courvoisier DS, Lamacchia C, Prat LM, Mahler M, Bentow C, Finckh A, Gabay C, Nissen MJ & Registry, on behalf of the physicians of the S. C. Q. M. (SCQM). (2020). Serum calprotectin: A promising biomarker in rheumatoid arthritis and axial spondyloarthritis. Arthritis Res Therapy 22:105. https:\/\/doi.org\/10.1186\/s13075-020-02190-3","DOI":"10.1186\/s13075-020-02190-3"},{"issue":"1","key":"11373_CR62","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s10974-008-9140-2","volume":"29","author":"T Nishimura","year":"2008","unstructured":"Nishimura T, Nakamura K, Kishioka Y, Kato-Mori Y, Wakamatsu J, Hattori A (2008) Inhibition of matrix metalloproteinases suppresses the migration of skeletal muscle cells. J Muscle Res Cell Motil 29(1):37\u201344. https:\/\/doi.org\/10.1007\/s10974-008-9140-2","journal-title":"J Muscle Res Cell Motil"},{"issue":"8","key":"11373_CR63","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.3899\/jrheum.101128","volume":"38","author":"S Arends","year":"2011","unstructured":"Arends S, van der Veer E, Groen H, Houtman PM, Jansen TLTA, Leijsma MK, Bijzet J, Limburg PC, Kallenberg CGM, Spoorenberg A, Brouwer E (2011) Serum MMP-3 level as a biomarker for monitoring and predicting response to etanercept treatment in ankylosing spondylitis. J Rhuematol 38(8):1644\u20131650. https:\/\/doi.org\/10.3899\/jrheum.101128","journal-title":"J Rhuematol"},{"issue":"6","key":"11373_CR64","doi-asserted-by":"publisher","first-page":"1846","DOI":"10.1002\/art.22589","volume":"56","author":"WP Maksymowych","year":"2007","unstructured":"Maksymowych WP, Landew\u00e9 R, Conner-Spady B, Dougados M, Mielants H, van der Tempel H, Poole AR, Wang N, van der Heijde D (2007) Serum matrix metalloproteinase 3 is an independent predictor of structural damage progression in patients with ankylosing spondylitis. Arthritis Rheum 56(6):1846\u20131853. https:\/\/doi.org\/10.1002\/art.22589","journal-title":"Arthritis Rheum"},{"issue":"8","key":"11373_CR65","first-page":"1753","volume":"34","author":"J-H Woo","year":"2007","unstructured":"Woo J-H, Lee H-J, Sung I-H, Kim T-H (2007) Changes of clinical response and bone biochemical markers in patients with ankylosing spondylitis taking etanercept. J Rhuematol 34(8):1753\u20131759. https:\/\/www.jrheum.org\/content\/34\/8\/1753","journal-title":"J Rhuematol"},{"issue":"5","key":"11373_CR66","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1007\/s00421-009-1063-0","volume":"106","author":"ML Urso","year":"2009","unstructured":"Urso ML, Pierce JR, Alemany JA, Harman EA, Nindl BC (2009) Effects of exercise training on the matrix metalloprotease response to acute exercise. Eur J Appl Physiol 106(5):655\u2013663. https:\/\/doi.org\/10.1007\/s00421-009-1063-0","journal-title":"Eur J Appl Physiol"},{"issue":"5","key":"11373_CR67","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1007\/s00421-023-05133-3","volume":"123","author":"A Raman","year":"2023","unstructured":"Raman A, Peiffer JJ, Hoyne GF, Lawler NG, Currie A, Fairchild TJ (2023) Exercise-induced responses in matrix metalloproteinases and osteopontin are not moderated by exercise format in males with overweight or obesity. Eur J Appl Physiol 123(5):1115\u20131124. https:\/\/doi.org\/10.1007\/s00421-023-05133-3","journal-title":"Eur J Appl Physiol"},{"issue":"2","key":"11373_CR68","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1007\/s11154-022-09758-1","volume":"24","author":"N Athanasiou","year":"2023","unstructured":"Athanasiou N, Bogdanis GC, Mastorakos G (2023) Endocrine responses of the stress system to different types of exercise. Reviews Endocr Metabolic Disorders 24(2):251\u2013266. https:\/\/doi.org\/10.1007\/s11154-022-09758-1","journal-title":"Reviews Endocr Metabolic Disorders"},{"issue":"1","key":"11373_CR69","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1111\/j.1469-7793.1999.287ad.x","volume":"515","author":"K Ostrowski","year":"1999","unstructured":"Ostrowski K, Rohde T, Asp S, Schjerling P, Pedersen BK (1999) Pro- and anti-inflammatory cytokine balance in strenuous exercise in humans. J Physiol 515(1):287\u2013291. https:\/\/doi.org\/10.1111\/j.1469-7793.1999.287ad.x","journal-title":"J Physiol"},{"key":"11373_CR70","doi-asserted-by":"crossref","unstructured":"Andersson \u00c5, Olsson MC, Torell A, Mogard E, Haglund E (2025) Effects on serum protein levels from one bout of high intensity interval training in individuals with axial spondyloarthritis and controls. Immunity, Inflammation and Disease (accepted)","DOI":"10.22541\/au.172248760.09512165\/v1"},{"key":"11373_CR71","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2019.01550","author":"\u00c9 Cerqueira","year":"2020","unstructured":"Cerqueira \u00c9, Marinho DA, Neiva HP, Louren\u00e7o O (2020) Inflammatory effects of high and moderate intensity exercise\u2014a systematic review. Front Physiol. https:\/\/doi.org\/10.3389\/fphys.2019.01550","journal-title":"Front Physiol"},{"key":"11373_CR72","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1186\/s13075-017-1350-9","volume":"19","author":"A Hartl","year":"2017","unstructured":"Hartl A, Sieper J, Syrbe U, Listing J, Hermann K-G, Rudwaleit M, Poddubnyy D (2017) Serum levels of leptin and high molecular weight adiponectin are inversely associated with radiographic spinal progression in patients with ankylosing spondylitis: results from the ENRADAS trial. Arthritis Res Therapy 19:140. https:\/\/doi.org\/10.1186\/s13075-017-1350-9","journal-title":"Arthritis Res Therapy"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-025-11373-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-025-11373-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-025-11373-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T18:05:36Z","timestamp":1766167536000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-025-11373-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,19]]},"references-count":72,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["11373"],"URL":"https:\/\/doi.org\/10.1007\/s11033-025-11373-7","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,19]]},"assertion":[{"value":"16 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"212"}}